In this study, the toxicity of bis (tri-n-butyltin) oxide (TBTO), a marine pollutant, in premature mouse testes and the correlation of a total tin concentration with toxicity were examined. Mice were treated by oral administration twice a week for four weeks from five weeks of age at doses of 0 mg/kg (control), 0.4 mg/kg, 2.0 mg/kg, or 10 mg/kg, and sacrificed on the day following the final administration. The control mice were administered with distilled water containing 0.2% ethanol as vehicle. Removed testes were used for determination of the testicular sperm head counts and for histological study or determination of the total tin concentration. The sperm head count was significantly decreased in the 2.0 mg/kg and 10 mg/kg administration groups, although the testicular weights of both groups were unchanged compared to that of the control. The histological study revealed that TBTO caused vacuolization of Sertoli cells in several seminiferous tubules that failed to organize, however, the frequencies of occurrence were low. The total tin concentration in the testis increased in a dose-dependent manner in inverse proportion to the reduction of sperm head counts. These results suggest that TBTO is potentially an anti-testicular compound in mice.
rganotin compounds such as tributyltin (TBT) are very active chemicals and are widely used as biocides in antifouling paints for ships and in agricultural chemicals [1] [2] [3] . The widespread use of organotin compounds causes environmental pollution, especially marine pollution. Organotin co mpounds released into the enviro nm ent , fo l lo w e d by fo o d c h ain ac c u m ul at io n an d bioconcentration, causes imposex to shellfish [4] . Therefore, organotin compounds may also have toxicity concerns for mammals.
The toxicities o f organotin compo unds in mammals (experimental animals and humans) were reviewed in several reports [1] [2] [3] 5] . Various reports showed bis (tri-n-butyltin) oxide (TBTO), tributyltin (TBT) and triphenyltin (TPT) to be immunot oxic inducing thymic a trophy a nd apoptosis, and activation of caspases in Jurkat Tlymphocytes [6] [7] [8] [9] , and they are also known to be developmental and reproductive toxicants. The embryotoxicities of TBTO in vitro and in vivo were Accepted for publication: July 26, 2002 Correspondence: K. Kumasaka reported by Davis et al. [10] and Krowke et al. [11] . Davis et al. reported that a marked decrease in maternal weight gain, an increase in resorption rate and a reduction of fetal weight were exhibited by gastric intubation of TBTO at 35 mg/kg per day on day 6 to 15 of gestation in pregnant mice. The teratogenic, developmental and reproductive toxicities of TBT in rats have also been documented [12] [13] [14] . Regarding the male reproductive toxicity of triorganotin compounds, there are a few reports describing TPT toxicities in histological studies of testes, fertility and spermatogenesis [15] [16] [17] . Snow et al. showed that 20 mg/kg body weight of TPT administration for 20 days via diet affected spermatogenesis in rats. Recently, a paper has been published concerning the toxicity of TBT on male reproduction. Omura et al. reported on twogeneration reproductive toxicity of TBT chloride in male rats [18] . In that study, homogenizationr e s i s t a n t s p e r m a t i d c o u n t w a s d e c r e a s ed significantly to approximately 80% of control value by dietary concentration of 125 ppm TBT chloride in the F1 generation and 25, 125 ppm TBT chloride in the F2 generation [18] . However, the relation of these toxicities to tin concentration in the testis was not reported.
In order to investigate effects of TBTO on male reproduction, the testicular weight, testicular sperm head counts and testicular histology were examined in premature mice. Furthermore, the testicular total tin concentration was determined to investigate the relation of its effect on male reproduction. The findings suggest that TBTO is potentially an anti-testicular compound in mice.
Materials and Methods

Animals
Male ICR mice were purchased from Japan SLC Inc. (Hamamatsu, Japan) at 4 weeks of age. The animals were maintained in an air-conditioned room at 22 ± 2 C with 30 to 70% relative humidity, and a constant 12 hr light/dark cycle. The mice were reared on a diet (AIN-93G, Nihon Nosan Kogyo Co. Inc., Japan) and tap water, ad libitum.
Chemicals and preparation
The bis (tri-n-butyltin) oxide (TBTO; 96% purity) was purchased from Aldrich Chemical Company, Inc. (Milwaukee, WI, USA). TBTO was dissolved in distilled water containing 0.2% ethanol (99.5%, Wako Pure Chemical Industries, Osaka, Japan). TBTO solutions were adjusted to 0.1 ml/10 g of body weight. These solutions were sonicated slightly for dispersion before each administration. All TBTO solutions were renewed before each treatment.
Experimental procedure
Two studies were performed. In the first experiment, testicular weight, testicular sperm head counts and histology were determined. In the second experiment, testicular weight, testicular sperm head counts and total tin concentration were determined.
In the both experiments, 5-week-old mice (body weight, 25-30 g) were distributed into four groups of 6 mice. The mice were treated orally twice a week (Tuesdays and Fridays) with 0.4 mg/kg, 2.0 mg/kg, or 10 mg/kg of TBTO from 5 weeks of age for 4 weeks. The highest concentration 10 mg/kg is about one of fifth of LD50 (55 mg/kg, mouse, po.). On the day following the final administration at 9 weeks of age (29 days after the first administration), the control and treated mice were sacrificed by exsanguination under diethyl ester anesthesia. Testes from each mouse were weighed, and one testis from an individual mouse was stored in saline at -20 C until testicular sperm head counting. The other testis was fixed in Bouin's solution for histological examination in the first experiment, or was stored at -80 C for determination of total tin concentration in the second experiment. Liver, kidney, and spleen were removed and weighed in both experiments to assess the general toxicities reported previously [1] [2] [3] 5] .
Testicular sperm head counting
The counting of testicular sperm head counts was performed as described by Meistrich [19] . Briefly, after the tunica albuginea was removed, testes were homogenized with 3 ml of saline and sonicated for 1 min. Each 20 µl of the solution were then counted by Thoma hemocytometer under a microscope.
Histological studies
The testes were fixed in Bouin's solution for 20 hours and embedded in paraffin according to routine procedures, and 3-µm sections were prepared. Sections were stained with hematoxylin and eosin.
Determinations of total tin concentrations in testes
Total tin concentration in the testis was measured by inductively coupled plasma mass spectrometry (ICP-MS). Optimum operating conditions of ICP-MS are shown in Table 1 . Individual testis from the control or treated mice were freeze-dried and transferred into a Teflon vial. The freeze-dried samples were digested with 2 ml of concentrated nitric a cid at room temperature for 5 hours followed by 2 hours at 140 C. After cooling, the samples were diluted with 20 ml of ultra pure water and 0.2 ml of indium internal standard (1 µg/ ml) were added for the assay.
Data analysis
All values are presented as mean ± SD and were compared between the control and TBTO-treated groups using Dunnet's multiple comparisons test. D i ff er e n c es of P< 0 . 05 w e r e c o n s id e r ed as statistically significant.
Results
Body weight gain and organ weights
The results of body weight gain and organ w ei g ht s w er e c o n s i s t e n t b e t w e en t h e t w o experiments of this study, and no mouse died during dosing. The body weight of mice in each group increased constantly during administration of TBTO. At the necropsy on the day after the final administration, there was no difference in the testicular weight between the treated groups and the control (control, 137 ± 25 mg; 0.4 mg/kg, 124 ± 22 mg; 2.0 mg/kg, 126 ± 16 mg; 10 mg/kg, 132 ± 21 mg in both experiments). Also, the weights of liver, kidney and spleen in treated mice were not different from those of the control mice in both experiments (data not shown).
Testicular sperm head counts
Testicular sperm head counting was performed to observe spermatogenesis in testes affected by TBTO. The data from the treated groups are expressed as a percentage of the average counts of the control (100%). Testicular sperm head count was reduced significantly to 60% of the control level by the administration of 10 mg/kg TBTO (P<0.01), and it also showed a significant decrease to 70% of the control level in the 2.0 mg/kg TBTO t r e a tm e n t g r o u p ( P < 0 . 0 5 , F i g . 1 ) . T h e s e obs erv atio ns were a lmo st ident ical in bot h experiments of this study.
Histological findings of the testis
In experiment 1, representative histological changes found in the TBTO-treated testis are shown in Fig. 2 . The control testis section ( Fig. 2A ) appeared well-differentiated and had w ellorganized seminiferous tubules. In contrast, several disorganized tubules showed vacuolization of Sertoli cells in the 10 mg/kg TBTO-treated testes (Fig. 2B) . Moreover, in some seminiferous tubules in this group, multinuclear giant cells and loss of germ cells appeared (data not shown). These changes were not observed in control testes using the same Bouin's solution and same fixation time. However, the observation frequencies were low and were not confirmed in 2.0 mg/kg or less of TBTO-treated testis. No abnormality in the spermatogonia, spermatocytes, spermatids, Leydig c e l l s a n d t h e b a se m e n t m e m b r a n e o f t h e seminiferous tubules were found in the TBTOtreated testes.
Total tin concentrations in the testes
To investigate the possibility that the reduction of sperm head counts and histological changes were related to TBTO administration, the total tin concentration in the testes was measured in experiment 2. As shown in Fig. 3 , total tin concentration in the testes was increased in the 2.0 mg/kg, and significantly increased in the 10 mg/kg TBTO administration groups (P<0.01) compared to that of the control in a dose-dependent manner, 
Discussion
The present study was designed to investigate the toxicity of TBTO on the testis in mice. In this study, it was revealed that the testicular sperm head counts decreased in TBTO-treated mature mice without any general toxicity when the mice were a dministered TBTO o rally during the premature period (from 5 weeks of age for 4 weeks).
To investigate the spermatogenesis affected by T B T O , te s t i c u l a r sp e r m h e a d c ou n t w a s determined. It is one of the parameters that can be a p pl ie d t o t h e q ua nt i t a t iv e a s s es s m en t o f reproductive risk. It also shows the integrated effect of chronic exposure of chemicals on all stages of spermatogenesis, while the effects on specific stages of spermatogenesis can be measured by a single dose of a chemical with selected intervals after administration [19] .
The mice treated for 4 weeks were sacrificed on the day after the final administration, day 29 after the first administration, and the testicular sperm head count is a measure of germ cell survival (e.g. differentiating spermatogonia, spermatocyte) [20] [21] [22] . Twenty-nine days is a sufficient period to allow differentiating spermatogonia, spermatocyte and round spermatid to differentiate into elongated spermatid, of which the head is sonication resistant; however the s urvival o f stem cells was not determined. In the present study, testicular sperm head count was decreased significantly to 60% of the control level by the administration of 10 mg/kg TBTO, and it was reduced significantly to 70% of the control level in the 2.0 mg/kg treatment group, although the testicular weights of both groups were not changed compared to that of the control in both experiments. The body weight gain and other organs weights were not different between the control and treated mice. We administered TBTO with a low dosage and decreased frequency to mice to exclude the general toxicity of TBTO reported previously [1] [2] [3] [5] [6] [7] [8] [9] . This result shows that TBTO administration affects spermatogenesis particularly differentiated germ cells in the mouse testes. A previous report by Omura et al. showed that sper mat id co unt w as reduced in F1 and F2 generations by feeding 125 ppm TBT chloride in a two-generation reproductive toxicity study in rats [18] . This result may show that TBT potentially affects the rodent male reproductive system. The reason for this reduction in sperm head count was not revealed in the present study, however a previous report showed that increased serum LH c on cent rat ion an d an inc reas ed num ber of immunoreactive LH cells in the pituitary were observed after TBTO-treatment in rats [5] , which may demonstrate a disorder of the endocrine system. Recently, it was also reported that TBT altered steroid hormone metabolism and inhibited the activity of aromatase and other P450-enzymes in rats, marine species and human granulose-like tumor cells [18, 23, 24] , therefore in mice, TBTO might also affect the endocrine system via the steroidogenesis pathway with toxic effects on the testicular function. In this study, we also tried to measure the serum testosterone level, however, we c ou ldn 't fin d t he exa c t ten den cy of ser um testosterone level in the TBTO-treated mice because of wide individual differences (data not shown). Further studies are needed to reveal the effects of TBTO on the endocrine system in mice. H i s t o lo g ic a l s t u d i e s w e r e p e r fo r m e d t o investigate the intensity of disorders and the regions damaged by TBTO in the testis. Several seminiferous tubules failed to organize, in which vacuolization of Sertoli cells appeared. Moreover, loss of germ cells and giant cells were observed in some seminiferous tubules (data not shown). However, these frequencies were low and these observations were not confirmed in the 2.0 mg/kg TBTO administration group in spite of observing a reduction of sperm counts. Therefore, we consider that these histological changes are not remarkable. Because we didn't perform a test such as a single administration to analyze cell m orta lity, or investigate the exact stage of spermatogenesis at which toxicity occurred in this study, we could not identify with precision the cell specific damage. H o w e v e r , d e g e n e r a t i o n o f g e r m c e l l s , spermatogonia, spermatocytes and spermatids were not observed in the histological test after administration of TBTO for four weeks, therefore, the reduction in the sperm head counts observed in this present study might relate to vacuolization of Sertoli cells in part.
As regards the concentration of tin in tissues, a dose-related increase of tin concentration was reported in the kidney, liver, brain and fat in rats and in the kidney, liver and fat in mice [5, 25] , however, the tin concentration in testes of TBTtreated mice had not been reported. To confirm whether the reduction of the testicular sperm head counts and the histological changes in treated mice were caused by administering TBTO, the testicular total tin concentration was determined. In the present study, total tin concentration in the testis incr eas ed in a do se-dependent m an ner ; its concentration was about 15-25 ng/100 mg of the testis in the 10 mg/kg treatment. This result suggests that the reduction of testicular sperm head counts was in inverse proportion to the increased and/or accumulated total tin concentration in a dose-dependent manner. However, we could not find any report of increased tin concentration in the testes affecting spermatogenesis in vivo and in vitro. Therefore, we speculate that the toxicities of TBTO on the testes were presumably due to increased total tin concentration in part, although the mechanism remains unclear. The accumulation of tin compounds such as TBTO and metabolic products in the treated mouse testes were not confirmed in the present study because all of organic compounds were digested by nitric acid and those were identified as inorganic compounds. According to previous reports [26, 27] , orally administered TBTs were rapidly dealkylated in the liver in rats and mice which may show that orally administered TBTs are easily metabolized in the liver and other tissues. Therefore, accumulated tin compounds in the treated mouse testes may have been metabolic products from TBTO mainly.
We conclude that treatment with TBTO in premature mice caused anti-testicular effects such as the reduction of sperm head counts but there were minimal histological changes on the testis.
